Production (Stage)
Alto Neuroscience, Inc.
ANRO
$3.03
$0.103.41%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.70M | 6.20M | 5.83M | 5.16M | 4.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.68M | 17.00M | 18.89M | 18.34M | 14.39M |
| Operating Income | -15.68M | -17.00M | -18.89M | -18.34M | -14.39M |
| Income Before Tax | -15.17M | -15.20M | -16.78M | -16.03M | -13.42M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.17M | -15.20M | -16.78M | -16.03M | -13.42M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.17M | -15.20M | -16.78M | -16.03M | -13.42M |
| EBIT | -15.68M | -17.00M | -18.89M | -18.34M | -14.39M |
| EBITDA | -15.51M | -16.83M | -18.76M | -18.23M | -14.29M |
| EPS Basic | -0.56 | -0.57 | -0.62 | -0.60 | -0.76 |
| Normalized Basic EPS | -0.33 | -0.35 | -0.39 | -0.37 | -0.48 |
| EPS Diluted | -0.56 | -0.57 | -0.62 | -0.60 | -0.76 |
| Normalized Diluted EPS | -0.33 | -0.35 | -0.39 | -0.37 | -0.48 |
| Average Basic Shares Outstanding | 27.05M | 26.77M | 26.96M | 26.91M | 17.60M |
| Average Diluted Shares Outstanding | 27.05M | 26.77M | 26.96M | 26.91M | 17.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |